1. Home
  2. XBIO vs JCSE Comparison

XBIO vs JCSE Comparison

Compare XBIO & JCSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XBIO
  • JCSE
  • Stock Information
  • Founded
  • XBIO N/A
  • JCSE 1999
  • Country
  • XBIO United States
  • JCSE Singapore
  • Employees
  • XBIO N/A
  • JCSE N/A
  • Industry
  • XBIO Biotechnology: Pharmaceutical Preparations
  • JCSE Miscellaneous manufacturing industries
  • Sector
  • XBIO Health Care
  • JCSE Consumer Discretionary
  • Exchange
  • XBIO Nasdaq
  • JCSE Nasdaq
  • Market Cap
  • XBIO 5.6M
  • JCSE 5.9M
  • IPO Year
  • XBIO N/A
  • JCSE 2022
  • Fundamental
  • Price
  • XBIO $3.66
  • JCSE $1.07
  • Analyst Decision
  • XBIO Hold
  • JCSE
  • Analyst Count
  • XBIO 1
  • JCSE 0
  • Target Price
  • XBIO N/A
  • JCSE N/A
  • AVG Volume (30 Days)
  • XBIO 192.9K
  • JCSE 7.2K
  • Earning Date
  • XBIO 08-12-2025
  • JCSE 05-15-2025
  • Dividend Yield
  • XBIO N/A
  • JCSE 8.49%
  • EPS Growth
  • XBIO N/A
  • JCSE N/A
  • EPS
  • XBIO N/A
  • JCSE 0.00
  • Revenue
  • XBIO $2,582,728.00
  • JCSE $14,126,397.00
  • Revenue This Year
  • XBIO $10.15
  • JCSE N/A
  • Revenue Next Year
  • XBIO $11.11
  • JCSE N/A
  • P/E Ratio
  • XBIO N/A
  • JCSE $230.58
  • Revenue Growth
  • XBIO 5.63
  • JCSE 6.92
  • 52 Week Low
  • XBIO $2.20
  • JCSE $0.71
  • 52 Week High
  • XBIO $5.27
  • JCSE $2.39
  • Technical
  • Relative Strength Index (RSI)
  • XBIO 52.54
  • JCSE 45.29
  • Support Level
  • XBIO $3.49
  • JCSE $1.02
  • Resistance Level
  • XBIO $3.77
  • JCSE $1.07
  • Average True Range (ATR)
  • XBIO 0.41
  • JCSE 0.04
  • MACD
  • XBIO -0.04
  • JCSE -0.01
  • Stochastic Oscillator
  • XBIO 35.79
  • JCSE 27.78

About XBIO Xenetic Biosciences Inc.

Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing innovative immuno-oncology technologies addressing difficult to treat cancers. The company's DNase technology is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which are involved in the progression of many human cancers. Xenetic is also focused on advancing its systemic DNase program into the clinic as an adjunctive therapy for pancreatic carcinoma and other locally metastatic solid tumors.

About JCSE JE Cleantech Holdings Limited

JE Cleantech Holdings Ltd is engaged in the manufacturing and selling of cleaning systems and other equipment that can be categorized into four different categories, namely aqueous washing systems, plating and cleaning systems, train cleaning systems, and other equipment, such as filtration units. The product lives of its cleaning systems and other equipment ranges from two to ten years. The company is also into designing, developing, and manufacturing other cleaning systems for various industrial end-use applications using its R&D and engineering capabilities. The company derives the majority of its revenue from the Sales of cleaning systems and other equipment. Geographically, the company derives a majority of its revenue from Singapore, followed by Malaysia.

Share on Social Networks: